Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines

Treeck, O and Haldar, C and Ortmann, O (2006) Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines. ONCOLOGY REPORTS, 15 (1). pp. 231-235. ISSN 1021-335X,

Full text not available from this repository. (Request a copy)

Abstract

An interaction between cellular estrogen response and melatonin signaling mediated by G-protein coupled receptors is present in breast cancer cells. In this study, the effect of antiestrogens on basal and melatonin-modulated expression of MT1 melatonin receptor in breast and ovarian cancer cells was examined. For this purpose, the effects of the selective estrogen receptor modulator tamoxifen and pure antiestrogen ICI 182,780 on MT1 expression in estrogen receptor (ER) a-positive and -negative breast and ovarian cancer cell lines cultured in medium supplemented with 1 nM 17-beta estradiol were assessed by Western blot analysis. We were able to detect expression of the MT1 receptor in SK-OV-3 and OVCAR-3 cells and report its up-regulation by melatonin in both ovarian cancer cell lines. MT1 expression was observed to be significantly weaker in ER alpha-positive MCF-7 and OVCAR-3 cells than in ER alpha-negative MDA-MB-231 and SK-OV-3 cells. Treatment with the pure antiestrogen ICI 182,780 increased MT1 receptor expression in OVCAR-3 ovarian cancer cells, but decreased MT1 expression in MCF-7 breast cancer cells. No effect of ICI 182,780 on MT1 expression was observed in the ERa-negative cell lines SK-OV-3 and MDA-MB-231. After treatment with 4-OH tamoxifen, down-regulation of basal MT1 receptor expression in ER alpha-positive MCF-7 cells and inhibition of melatonin-induced up-regulation of MT1 in OVCAR-3 ovarian cancer cells were observed. In contrast, treatment with 4-OH tamoxifen increased the MT1 receptor level in ERa-negative SK-OV-3 ovarian cancer cells. Our findings support the existence of close interaction between estrogen and melatonin signaling. Moreover, our data suggest that melatonin signaling is modulated by antiestrogens in breast and ovarian cancer cells.

Item Type: Article
Uncontrolled Keywords: ESTROGEN-RECEPTOR; TRANSGENIC MICE; PINEAL HORMONE; MCF-7; PROLIFERATION; OVEREXPRESSION; antiestrogen; melatonin; melatonin receptor; breast cancer; ovarian cancer
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 03 Mar 2021 08:40
Last Modified: 03 Mar 2021 08:40
URI: https://pred.uni-regensburg.de/id/eprint/35248

Actions (login required)

View Item View Item